RemeGen Co., Ltd. (9995.HK)
HKD 33.4
(10.6%)
HKD 33.4
(10.6%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.80 CNY | -48.94% |
| 2022 | -1.88 CNY | -429.82% |
| 2021 | 0.57 CNY | 132.02% |
| 2020 | -1.78 CNY | -79.8% |
| 2019 | -0.99 CNY | -76.79% |
| 2018 | -0.56 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.80 CNY | -23.08% |
| 2024 Q1 | -0.65 CNY | 26.97% |
| 2023 Q3 | -0.61 CNY | 12.86% |
| 2023 FY | - CNY | -48.94% |
| 2023 Q4 | -0.89 CNY | -45.9% |
| 2023 Q2 | -0.70 CNY | -16.67% |
| 2023 Q1 | -0.60 CNY | -3.45% |
| 2022 Q3 | -0.37 CNY | 2.63% |
| 2022 Q1 | -0.59 CNY | -129.65% |
| 2022 Q2 | -0.38 CNY | 35.59% |
| 2022 FY | - CNY | -429.82% |
| 2022 Q4 | -0.58 CNY | -56.76% |
| 2021 Q3 | -0.50 CNY | 5.66% |
| 2021 Q1 | -0.38 CNY | 17.39% |
| 2021 FY | - CNY | 132.02% |
| 2021 Q2 | -0.53 CNY | -39.47% |
| 2021 Q4 | 1.99 CNY | 498.0% |
| 2020 Q3 | -0.46 CNY | -24.32% |
| 2020 Q4 | -0.46 CNY | 0.0% |
| 2020 Q2 | -0.37 CNY | 32.73% |
| 2020 Q1 | -0.55 CNY | -129.17% |
| 2020 FY | - CNY | -79.8% |
| 2019 Q1 | -0.18 CNY | 28.0% |
| 2019 FY | - CNY | -76.79% |
| 2019 Q4 | -0.24 CNY | 0.0% |
| 2019 Q3 | -0.24 CNY | 0.0% |
| 2019 Q2 | -0.24 CNY | -33.33% |
| 2018 Q4 | -0.25 CNY | 0.0% |
| 2018 Q2 | -0.16 CNY | 0.0% |
| 2018 Q1 | -0.16 CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 Q4 | -0.16 CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 25325.225% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 155655.556% |